Summary
T cells have a weak membrane transport actitivity for cystine but strong transport activity for cysteine. Even moderate variations of the cysteine concentration affect T cell functions in spite of the high concentration of cystine in cultures with physiological amino acid concentrations. The IL-2 dependent DNA synthesis and the activation of cytotoxic T cells are positively regulated by cysteine, while the activity of the transcription factor NFkB and the production of IL-2 are stimulated by active oxygen species and inhibited by cysteine or GSH. Macrophages, in contrast to T cells, take up more cystine than they need and release the excess after intracellular reduction as cysteine into the extracellular space. This “cysteine pumping activity” of macrophages raises intracellular GSH levels and DNA synthesis of T cells in the vicinity. The difference between the cystine transport activities of T cells and macrophages, therefore, enables T cells to switch between prooxidant and antioxidant states. The “cysteine pump” favors selectively the antigen-specific T cells that are about to be stimulated by antigen-presenting macrophages. The capacity of macrophages to take up cystine and to release cysteine is inhibited, however, by elevated extracellular glutamate concentrations. Elevated plasma glutamate levels have been found in several pathological conditions including cancer and HIV-infection. In HIV-infected patients, the hyperglutamataemia is aggravated by hypocystinaemia and hypocysteinaemia. Our studies, therefore, suggest that the cysteine supply is impaired in several pathological conditions with immunodeficiencies including AIDS. N-acetyl-cysteine (NAC) is a safe and well established drug that may be considered for the treatment of patients with HIV-infection.
Similar content being viewed by others
References
Bannai S (1986) J Biol Chem 261: 2256–2263
Buhl R, Holroyd K, Mastrangeli A, Cantin AM, Jaffe HA, Wells FB, Saltini C, Crystal RG (1989) Lancet ii: 1294–1298
Collart MA, Baeuerle P, Vassalli P (1990) Mol Cell Biol 10: 1498–1506
Cross SL, Halden NF, Lenardo MJ, Leonard WJ (1989) Science 244: 466–469
Dröge W, Eck H-P, Betzler M, Drings P, Ebert W (1988a) J Cancer Clin Oncol 114: 124–128
Dröge W, Eck H-P, Näher H, Pekar U, Daniel V (1988b) Biol Chem Hoppe Seyler 369: 143–148
Eck H-P, Dröge W (1989a) Biol Chem Hoppe Seyler 370: 109–113
Eck H-P, Gmünder H, Hartmann M, Petzoldt D, Daniel V, Dröge W (1989b) Biol Chem Hoppe Seyler 370: 101–108
Eck H-P, Betzler M, Schlag P, Dröge W (1990) J Cancer Res Clin Oncol 116: 648–650
Eck H-P, Stahl-Hennig C, Hunsmann G, Dröge W (1991) Lancet 10 Aug: 346–347
Gmünder H, Eck H-P, Benninghoff B, Roth S, Dröge W (1990a) Cell Immunol 129: 32–46
Gmünder H, Roth S, Eck H-P, Gallas H, Mihm S, Dröge W (1990b) Cell Immunol 130: 520–528
Gmünder H, Dröge W (1991a) Cell Immunol (in press)
Gmünder H, Eck H-P, Dröge W (1991b) Eur J Biochem (in press)
Hishinuma I, Ishii T, Watanabe H, Bannai S (1986) In Vitro Cell Dev Biol 22: 127–134
Ishii T, Sugita Y, Bannai S (1987) J Cell Physiol 133: 330–336
Klebanoff SJ, Vadas MA, Harlan JM, Sparks LH, Gamble JR, Agosti JM, Waltersdorph AM (1986) J Immunol 136: 4220–4225 Lahdevirta J, Maury CPJ, Teppo A-M, Repo H (1988) Am J Med 85: 289–291
Makowske M, Christensen HN (1982) J Biol Chem 257: 5663–5670
Matsubara T, Ziff M (1986) J Cell Physiol 127: 207–210
Meier B, Radeke HH, Selle S, Younes M, Sies H, Resch K, Habermehl GG (1989) Biochem J 263: 539–545
Meier B, Radeke HH, Selle S, Habermehl GG, Resch K, Sies H (1990) Biol Chem Hoppe Seyler 371: 1021–1025
Mihm S, Dröge W (1990) Immunobiology 181: 245
Mihm S, Ennen J, Pessara U, Kurth R, Dröge W (1991) AIDS 5: 497–503
Osborn L, Kunkel S, Nabel GJ (1989) Proc Natl Acad Sci USA 86: 2336–2340
Reddy MM, Grieco MH (1988) AIDS Res Hum Retroviruses 4: 115–120
Roederer M, Staal FJT, Raju PA, Ela SW, Herzenberg LA (1990) Proc Natl Acad Sci USA 87: 4884–4888
Roederer M, Staal FJT, Raju PA, Herzenberg LA, Herzenberg LA (1991) In: 3rd TNF and Related Cytokines Conference, Nov. 1990. Karger, Basel (in press)
Rosen GM, Freeman BA (1984) Proc Natl Acad Sci USA 81: 7269–7273
Rosenberg ZF, Fauci AS (1989) Clin Immunol Immunopathol 50: S149-S156
Roth S, Dröge W (1987) Cell Immunol 108: 417–424
Roth S, Dröge W (1991) Eur J Immunol (in press)
Schreck R, Rieber P, Baeuerle PA (1991) EMBO J 10: 2247–2258
Staal FJT, Roederer M, Herzenberg LA, Helzenberg LA (1990) Proc Natl Acad Sci USA 87: 9943–9947
Takada A, Bannai S (1984) J Biol Chem 259: 2441–2445
Ullmann KS, Northrop JP, Verweij CL, Crabtree GR (1990) Annu Rev Immunol 8: 421–452
Watanabe H, Bannai S (1987) J Exp Med 165: 628–640
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dröge, W., Eck, H.P., Gmünder, H. et al. Dysregulation of plasma amino acid levels in HIV-infection and cancer and its relevance for the immune system. Amino Acids 1, 193–198 (1991). https://doi.org/10.1007/BF00806916
Issue Date:
DOI: https://doi.org/10.1007/BF00806916